SCHEMBL5151895

SCHEMBL5151895

COc1cc(CC(=O)CNC(C)Oc2ccc(C(=O)O)cc2N2CCCCC2)ccc1NC(=O)Nc1ccccc1F

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.44
▸ GFER P55789 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.42
▸ ERAP1 Q9NZ08 3/20 0.42
▸ ERAP2 Q6P179 2/20 0.42
▸ ITGA4 P13612 6/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ PYGL P06737 1/20 0.41
▸ ABCC8 Q09428 1/20 0.40
▸ LMNA P02545 2/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5155115 0.94 GAA (0.44) GAAGFERNPSR1ITGA4ALDH1A1
SCHEMBL5154993 0.92 ITGA4 (0.47) GAAGFERNPSR1ERAP1ERAP2
SCHEMBL5155630 0.87 PYGL (0.45) ITGA4ALDH1A1PYGLMEN1KMT2A
SCHEMBL5151886 0.86 GAA (0.45) GAAGFERNPSR1ITGA4ALDH1A1
SCHEMBL5150028 0.86 PYGL (0.45) ITGA4ALDH1A1PYGLMEN1KMT2A
SCHEMBL5151889 0.86 GAA (0.44) GAAGFERNPSR1ERAP1ERAP2
SCHEMBL5157084 0.84 ALDH1A1 (0.46) ITGA4ALDH1A1PYGLMEN1KMT2A
SCHEMBL14558616 0.81 GAA (0.44) GAAGFERNPSR1ERAP1ERAP2
SCHEMBL5152504 0.81 PYGL (0.45) GAANPSR1ITGA4ALDH1A1PYGL
SCHEMBL5150320 0.81 PYGL (0.48) ITGA4ALDH1A1PYGLMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7179819-B2 VLA-4 inhibitor compounds DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-02-20 — — US disclosed
US-6756378-B2 BENZYL -UREA, -THIOUREA, OR -GUANIDINE DERIVATIVES THAT INHIBIT THE BINDING OF LIGANDS TO ALPHA 4 BETA 1 INTEGRIN (VLA-4) PHARMACOPEIA DRUG DISCOVERY, INC. 2004-06-29 — — US disclosed
Send feedback